Clove (Syzygium aromaticum) and its phytochemicals in ruminant feed: an updated review

Effects of clove (Syzygium aromaticum) extract on antibacterial activity, phytochemical properties, and storage quality of flavored milk beverages

The antibacterial efficacy of clove extracts (Syzygium aromaticum) prepared using 80% ethanol and water against pathogenic bacteria was evaluated, along with the development of a novel antimicrobial milk beverage incorporating these extracts. Seven flavored milk beverage (FMB) treatments were prepared: a control and 6 with clove extracts at 0.5%, 0.7%, and 1% for each solvent. The effects on physicochemical, phytochemical, antioxidant, microbiological, color, and sensory properties were assessed over 15 d of storage at 4 ± 1°C. The ethanolic clove extract exhibited significantly higher antimicrobial activity against Staphylococcus aureus, Listeria monocytogenes, Escherichia coli O157, Salmonella typhi, and Klebsiella pneumoniae, with inhibition zone diameters of 20 mm, 21 mm, 20 mm, 19 mm, and 20 mm, respectively, compared with the aqueous extract. On d 0, the sample of 1% ethanolic clove extract (FMB3) showed the highest proximate analysis values, including TS (22.41%), protein (4.61%), fat (4.58%), ash (0.97%), and gross energy (108.65 Kcal). It also showed the highest pH (6.7), flavor score (19.20), texture score (9), and overall acceptability score (39.50), and the lowest carbohydrate content (12.27%), lightness value (69.60), and yellowness value (97.47). Over the 15-d storage period, the total phenolic content (TPC), total flavonoid content (TFC), and total antioxidant capacity (TAC) increased, with the FMB3 sample exhibiting the highest TPC (58.70 mg/100 g), TFC (46.15 mg/100 g), and TAC (487.10 mg/100 g). All beverages remained free from yeasts and molds, and FMB3 exhibited the lowest bacterial count (5.13 log cfu/mL). The results indicate that ethanolic clove extract effectively inhibits spoilage and pathogenic organisms and enhances the sensory and functional properties of FMB. This finding offers a promising approach for improving the quality and safety of dairy products.

Inclusion of antimicrobial and antioxidant spices into milk candy towards enhancement of nutrient contents and bio-functional activities

Herbs and spices are known for their health benefits and thus, commonly used in foods to enhance taste, flavour and shelf life. This study produced milk candy with medicinal spices, assessed their proximate composition, prebiotic, and antioxidant activities using standard methods. Phenol contents of extracts from Aframomum melegueta (25.40 mg/100g) and Ocimum gratissimum (24.80 mg/100g) were not significantly different (p ≥ 0.05). Extracts from Ocimum gratissimum (5.50 mg/100g), Piper guineense (5.50 mg/100g), Cinnamomum burmannii (5.10 mg/100g), and Trigonella foenum-graecum (5.20 mg/100g) have similar (p ≥ 0.05) terpenoid content. Zones of inhibition displayed by the spices against indicator microorganisms ranged from 5.20 mm to 10.30 mm with MIC values of 50-200 μg/mL. Extracts from Ocimum gratissimum, Aframomum melegueta, and Xylopia aethiopica scavenged 1, 1-diphenyl-2-picrylhydrazyl (DPPH) with similar (p ≥ 0.05) values of 90.6 %, 91.5 %, and 92.5 %, respectively. The crude fibre of milk candy with spices increased from 6.90 to 8.10 % when compared (p ≥ 0.05) to milk candy without spices (3.90 %). Milk candies with Xylopia aethiopica and Zingiber officinale have the same scavenging activity of 65.80 % against DPPH. Milk candy fortified with Cuminum cyminum supported the growth of probiotics; Lactobacillus fermentum with the highest values of 8.30 × 105 cfu/mL and 6.90 × 105 cfu/mL for Lactobacillus acidophilus. Addition of spices to milk candy gain wide acceptance by consumers due to savory. Medicinal herbs and spices can be successfully incorporated into milk products to enhance their bio-functional potentials, and to alleviate the intolerance of individual that are allergic to dairy products.

Therapeutic Potential of Clove Oil in Mitigating Cadmium-Induced Hepatorenal Toxicity Through Antioxidant, Anti-Inflammatory, and Antiapoptotic Mechanisms

Hazardous heavy metals, particularly cadmium (Cd), are widely distributed in the environment and cause oxidative stress in various animal and human organs. Clove oil (CLO), a common aromatic spice, has been used as a traditional medication as it has potent anti-inflammatory, antioxidant, and hepatoprotective properties.

BACKGROUND/OBJECTIVES

This study aimed to investigate the antioxidant, antiapoptotic, and anti-inflammatory effects of clove oil (CLO) against hepatorenal toxicity induced by cadmium (Cd).

METHODS

Twenty rats were equally divided into four groups: a control group, a Cd group treated with 15 mg/kg b.wt CdCl2, a CLO group administered 200 mg/kg b.wt CLO, and a Cd+CLO group. All groups were orally treated for 4 weeks.

RESULTS

Cadmium (Cd) exposure caused anemia and hepatorenal damage, as evidenced by increased serum levels of urea, creatinine, uric acid, total bilirubin (including its direct and indirect fractions), and elevated activities of liver enzymes such as alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP). However, total protein and albumin levels decreased. Furthermore, there was a decrease in the levels of glutathione, glutathione transferase, and catalase in the liver antioxidant profiles. Meanwhile, malondialdehyde levels increased. Cadmium toxicity caused elevated expression of liver apoptosis markers, such as tumor necrosis factor-alpha (TNF-α) and caspase-3, and inflammation. CLO ameliorated the oxidative effects of Cd through decreasing urea (27.4%), creatinine (41.6%), liver enzymes, and hepatic apoptotic markers while increasing levels of total protein, albumin, and hepatic values of SOD (60.37%), CAT (64.49%), GSH (50.41%), and GST (9.16%).

CONCLUSIONS

Hematological and biochemical parameters, as well as the antioxidant system, improved following clove oil treatment, leading to a reduction in hepatorenal damage. Therefore, it is possible to conclude that CLO protects rats from inflammation, apoptosis, and hepatorenal oxidative damage caused by Cd poisoning. Comprehensive translational research is required to validate CLO's efficacy and safety of use in humans. Future studies should focus on elucidating the precise molecular mechanisms, optimal dosing strategies, and potential synergistic effects of CLO with other therapeutic agents.

The study of structure and effects of two new proanthocyanidins from Anogeissus pendula leaves on rumen enzyme activities

Two novel proanthocyanidins, (2R, 3R)-(+)-Gallocatechin-(4β → 8)4-(2R, 3R)-(+)-gallocatechin (compound 1) and 3-O-galloyl-(2S, 3S)-(-)-epicatechin-(4α → 8)-[3-O-galloyl-(2S, 3S)-(-)-epicatechin (4α → 8)]2-(2S, 3S)-(-)-epicatechin (compound 2), were structurally characterized from leaves of Anogeissus pendula. The structures were determined by ultraviolet spectroscopy (UV), proton nuclear magnetic resonance (¹H NMR), ¹³C NMR, and heteronuclear multiple bond correlation. Molinspiration and Osiris property explorer applications were used to predict bioactivity and drug score. Drug scores of 0.08 and 0.05 were predicted for compounds 1 and 2, respectively. Predicted bioactivity scores were high. Due to their molecular weight, chemical structure, and conformation, the newly discovered proanthocyanidins possess an inclination to interact with proteins. Based on this premise, both compounds were subjected to in vitro testing against ruminal enzymes. They exhibited significant inhibition activities (p < 0.01) with a range of half maximal effective concentration (EC₅₀) of 14.80-17.88 mg/mL of glutamic oxaloacetic transaminase in both protozoa and bacteria fractions. The ruminal glutamic pyruvic transaminase activity was significantly inhibited (p < 0.01) from EC₅₀ 12.59-16.29 mg/mL, and R-cellulase inhibition was recorded with EC₅₀ 18.20-21.98 mg/mL by compounds 1 and 2, respectively. Protease activity decreased with increasing incubation time and concentration of both compounds. The novel proanthocyanidins have potential roles in improving feed conversion ratios and in drug development.

Chemical Composition and Evaluation of Antifungal and Insecticidal Activities of Essential Oils Extracted from Jambosa caryophyllus (Thunb.) Nied: Clove Buds

Jambosa caryophyllus has been used in traditional phytotherapy as a treatment against infections. In the present work, essential oils extracted from clove buds (Jambosa caryophyllus ) (EO-JC) were investigated for their composition, antifungal, and insecticidal properties. Extraction of EO-JC was performed by use of hydrodistillation using a Clevenger-type apparatus, and the EOs were analyzed by gas chromatography coupled with mass spectrometry (GC-MS). Antifungal activity of EO-JC was evaluated by the use of solid-state diffusion (disc method) and microdilution to determine the minimum inhibitory concentration (MIC), against three strains of fungus, Aspergillus niger, Aspergillus flavus, and Fusarium oxysporum. Insecticidal activity of EO-JC against the cowpea weevil, Callosobruchus maculatus, was determined to assess utility of EO-JC to control this pest. Several exposures including inhalation and contact were used to determine lethality, as well as the repulsion test was conducted at concentrations of 4, 8, 16, and 32 μL EO-JC. Characterization of EO-JC by GC/MS revealed 34 compounds accounting for 99.98% of the mass of the extract. The predominant compound was eugenol (26.80%) followed by β-caryophyllene (16.03%) and eugenyl acetate (5.83%). The antifungal activity of EO-JC on solid media exhibited inhibitions in the range of 49% to 87%, and MIC was between 3.125 and 7.80 μg EO-JC/mL. Insecticidal activity, as determined by the use of the inhalation test, and expressed as the LD₅₀ and LD₉₅ after 96 hours of exposure was 2.32 and 21.92 μL/L air, respectively. In the contact test, a 96-hour exposure resulted in LD₅₀ and LD₉₅ of 5.51 and 11.05 μL/L of air, respectively. EO-JC exhibited insecticidal activity against fungi and pest chickpea weevil.

Culinary Spices in Food and Medicine: An Overview of Syzygium aromaticum (L.) Merr. and L. M. Perry [Myrtaceae]

Spices-dried aromatic parts of plants (leaves, seeds, bark, roots, rhizomes, buds, etc) used to enhance flavour, taste and colour (sensory quality) of foods, are increasingly finding other useful roles in healthcare beyond their primary use as culinary organoleptic enhancers. Several spices are currently being investigated for their potential health benefits, because of the failing efficacy, toxicity and high cost associated with conventional drugs. One such spice: Syzygium aromaticum (L.) Merr. and L.M.Perry [Myrtaceae] (Clove), has a multi-dimensional role in diet, medicine, functional foods and nutraceuticals, agriculture, among other industries. Peer-reviewed articles, mostly from PubMed and Google Scholar, were consulted for the purpose of this review. The nutritional and phytochemical contents, selected biological activities as well as some functional foods and beverages of clove and their uses for human health are presented. Although these observations are largely empirical, the efficacious attributes have led to their pharmacological applications in the indigenous system of medicine all over the world and bridge between food, diet and medicine. Considering the GRAS status of clove, more studies on bioavailability, accumulation, toxicity, dosage and efficacy of clove as a spice drug or functional foods in biological systems especially in humans are required. Meanwhile, clove and its products can be used as co-adjuvants in the prevention, treatment and management of chronic diseases. Further, many applications of clove in food, health, cosmetics, pharmaceutics, nanoparticles and agricultural industries are still open for investigations.

Effects of cinnamaldehyde on glucose-6-phosphate dehydrogenase activity, some biochemical and hematological parameters in diabetic rats

CONTEXT

Diabetes is a metabolic disorder related to blood insulin deficiency and high glucose level. Cinnamaldehyde is an important component of cinnamon and has an effect on blood glucose.

OBJECTIVE

It was aimed to investigate the the effect of cinnamaldehyde on the liver glutathione (GSH), glucose-6-phosphate dehidrogenase (G6PD) activity, blood glucose, protein, lipid and erythrocyte parameters, live weight in diabetic rats.

MATERIAL AND METHODS

Rat used for this research were divided 4 group as control, diabetic, cinnamaldehyde and diabetic + cinnamaldehyde group. The live weight and fasting blood glucose level, taken from tail vein were recorded every ten days. End of the trail the blood samples were taken from rats. Biochemical parameters with autoanalyzer and hematological parameters with blood cell counter were determined in blood. The activity of G6PD and GSH amounts were measured with ELISA in the liver tissues.

RESULTS

Blood sugar, triglyceride, total cholesterol, VLDL, LDL, and urea levels increased in diabetic rats, and cinnemaldehyde significantly decreased these parameters. Cinnemaldehyde also showed a positive effect on body weight, blood total protein, and mean corpuscular volume in diabetes. A decrease in HbA1c and an increase in liver G6PD, GSH activity were found in treatment group, but these changes were not statistically significant.

CONCLUSION

In conclusion, the antidiabetic, hypolipidemic and antioxidant effects of cinnamaldehyde were determined. It has also been shown to improve anemia, ürea levels and weight loss.